CAS 1174014-05-1

Ublituximab

CAS: 1174014-05-1

Ublituximab, a CD20-directed cytolytic monoclonal antibody, is an immunomodulator used in the treatment of multiple sclerosis.

Reinheit: 95% - 98.6% (SDS-PAGE); 97.1% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 144.49 kDa

Ref: TM-T76966

Ublituximab

CAS: 1174014-05-1

Anti-CD20 chimeric monoclonal antibody; treatment of multiple sclerosis

Ref: 3D-CLA1274